Review

Published on 16 Mar 2023

Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment

in Pharmacology of Anti-Cancer Drugs

Monika Kaurav
Sakina Ruhi
Husni Ahmed Al-Goshae
Ashok Kumar Jeppu
Dhani Ramachandran
Ram Kumar Sahu
Ashish Kumar Sarkar
Jiyauddin Khan
Abu Md Ashif Ikbal

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159131

6,997 views
17 citations

Review

Published on 15 Mar 2023

Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery

in Pharmacology of Anti-Cancer Drugs

Shivani Mishra
Tanvi Bhatt
Hitesh Kumar
Rupshee Jain
Satish Shilpi
Vikas Jain

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101320

3,276 views
6 citations

Original Research

Published on 14 Mar 2023

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Jiankang Xiang
Chuan Liu
Qingmin He
Pengzhan He
Weiguo Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122011

3,100 views
3 citations

Review

Published on 14 Mar 2023

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?

in Pharmacology of Anti-Cancer Drugs

Chunxue Zhang
Yuxiang Fei
Hui Wang
Sheng Hu
Chao Liu
Rong Hu
Qianming Du

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1113378

7,313 views
28 citations

Original Research

Published on 14 Mar 2023

Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis

in Pharmacology of Anti-Cancer Drugs

Tingting Zhang
Mingnan Cao
Bin Zhao
Chen Pan
Li Lin
Chuanhao Tang
Zhigang Zhao
Jingli Duan
Li Wang
Jun Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1133551

3,580 views
6 citations

Systematic Review

Published on 13 Mar 2023

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

in Pharmacology of Anti-Cancer Drugs

Siyuan Zeng
Daju Liu
Yongai Yu
Lei Zou
Xianyu Jin
Bing Liu
Lifeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1111061

3,060 views
4 citations

Original Research

Published on 13 Mar 2023

Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy

in Pharmacology of Anti-Cancer Drugs

Liangbo Dong
Shengnan Zhou
Xuesong Bai
Xiaodong He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090895

3,184 views
4 citations

Original Research

Published on 13 Mar 2023

Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota

in Pharmacology of Anti-Cancer Drugs

E. Sun
Xiangqi Meng
Zhaoxia Kang
Huimin Gu
Mingyu Li
Xiaobin Tan
Liang Feng
Xiaobin Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123819

3,891 views
5 citations

Original Research

Published on 13 Mar 2023

Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients

in Pharmacology of Anti-Cancer Drugs

Mei Meng
Rui Gao
Zixue Liu
Fengxiang Liu
Shiyu Du
Yizhi Song
Jian He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1085509

2,706 views
2 citations

Original Research

Published on 10 Mar 2023

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents

in Pharmacology of Anti-Cancer Drugs

Yan Wang
Yuanyuan Hu
Ting Wang
Guowei Che
Lu Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123834

3,029 views
2 citations

Original Research

Published on 09 Mar 2023

Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value

in Pharmacology of Anti-Cancer Drugs

Tiansheng Cao
Hongsheng Wu
Tengfei Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1086309

2,811 views
1 citation

Review

Published on 09 Mar 2023

Biosynthesis of anticancer phytochemical compounds and their chemistry

in Pharmacology of Anti-Cancer Drugs

Amandeep Dogra
Jitender Kumar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136779

7,558 views
13 citations

Original Research

Published on 09 Mar 2023

Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Shuang Li
Dawei Zou
Zhaoqian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1127557

2,060 views
1 citation

Original Research

Published on 09 Mar 2023

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy

in Pharmacology of Anti-Cancer Drugs

Jia-Si Liu
Jun-Yan Liu
Qi Xiao
Xiang-Ping Li
Juan Chen
Zhao-Qian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119837

1,944 views
3 citations

Review

Published on 09 Mar 2023

Nanotechnological strategies to increase the oxygen content of the tumor

in Pharmacology of Anti-Cancer Drugs

Junjie Zhang
Kaiyuan Tang
Runqi Fang
Jiaming Liu
Ming Liu
Jiayi Ma
Hui Wang
Meng Ding
Xiaoxiao Wang
Yanni Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140362

3,341 views
9 citations

Original Research

Published on 08 Mar 2023

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Wei Zhang
Xi Jiang
Youcheng Zou
Lihua Yuan
Xiaobo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1092767

3,768 views
8 citations

Navigation group

Articles

Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment

Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?

Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy

Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota

Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents

Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value

Biosynthesis of anticancer phytochemical compounds and their chemistry

Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy

Nanotechnological strategies to increase the oxygen content of the tumor

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma